Enhanced solubility and bioavailability of sibutramine base by solid dispersion system with aqueous medium

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Systems
• Physical Chemistry

Background:

• Sibutramine base is a poorly water-soluble drug, limiting its oral bioavailability.
• Developing effective drug delivery systems is crucial for improving the therapeutic efficacy of hydrophobic drugs like sibutramine.

Purpose of the Study:

• To develop a novel sibutramine base-loaded solid dispersion with enhanced solubility and bioavailability.
• To investigate the effects of various excipients (HPMC, poloxamer, citric acid) on sibutramine solubility.
• To evaluate the physicochemical properties, dissolution, and pharmacokinetic profile of the developed solid dispersion.

Main Methods:

• Preparation of sibutramine base-loaded solid dispersions using spray-drying technique.
• Characterization of solid dispersions using Scanning Electron Microscopy (SEM), Differential Scanning Calorimetry (DSC), and X-ray Powder Diffraction (XRPD).
• In vitro dissolution studies and in vivo pharmacokinetic evaluation in rats compared to a commercial product (Reductil).

Main Results:

• Two types of solid dispersions were formed: spherical with smooth surfaces and irregular with rough surfaces.
• The irregular form did not alter the crystalline structure of sibutramine, suggesting surface modification.
• The optimal formulation (sibutramine base/HPMC/poloxamer/citric acid at 5/3/3/0.2) achieved a maximum solubility of approximately 3 mg/ml.
• The optimized solid dispersion exhibited comparable plasma concentration, Area Under the Curve (AUC), and C(max) to the commercial product in rats.

Conclusions:

• The developed spray-dried solid dispersion effectively enhances the aqueous solubility of sibutramine base.
• The novel solid dispersion system demonstrates potential for improving the bioavailability of poorly water-soluble sibutramine.
• This formulation offers a promising alternative for delivering sibutramine with potentially similar efficacy to existing products.